當(dāng)前位置: 首頁 » 產(chǎn)品 » 搜索

CCT129202
CCT129202 is a Aurora kinase inhibitor with IC50 of 0.0420.022, 0.1980.05, and 0.2270.064 uM for Aurora A, Aurora B, and
2015-12-25 17:06 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1252.00/5mg
05mg起訂
詢價(jià)

HMN-214
HMN-214(IVX214) is a potent PLK1 inhibitor an average IC50 of 0.12 M.IC50 Value: 0.12 MTarget: PLK1in vitro: HMN-214 is
2015-12-25 17:04 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

7217.00/50mg
050mg起訂
詢價(jià)

PHA-680632
PHA-680632 is potent inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 27 nM, 135 nM and 120 nM, respectively.公
2015-12-25 17:02 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1252.00/5mg
05mg起訂
詢價(jià)

Rigosertib (sodium)
Rigosertib sodium (ON-01910 sodium) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM.公司介紹：MedChemExpres
2015-12-25 17:00 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1534.00/5mg
05mg起訂
詢價(jià)

JNJ-7706621
JNJ-7706621 is pan-CDK inhibitor with the highest potency on CDK1/2 with IC50 of 9 nM/4 nM and showing 6-fold selectivit
2015-12-25 16:58 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1507.00/5mg
05mg起訂
詢價(jià)

BIIB021
BIIB021(CNF2024) is an orally available, fully synthetic small-molecule inhibitor of HSP90 with Ki and EC50 of 1.7 nM an
2015-12-25 16:56 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

6026.00/100mg
0100mg起訂
詢價(jià)

AZD1152-HQPA
AZD1152-HQPA is the active metabolite of AZD-1152, AZD1152-HQPA (Barasertib) is a highly selective Aurora B inhibitor wi
2015-12-25 16:52 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

837.00/5mg
05mg起訂
詢價(jià)

Alvespimycin (hydrochloride)
Alvespimycin Hcl(17-DMAG;NSC 707545) is a potent, water-soluble HSP90 inhibitor with IC50 of 62 nM.IC50 Value: 62 nMTarg
2015-12-25 16:50 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

7311.00/500mg
0500mg起訂
詢價(jià)

Danusertib
Danusertib (PHA-739358) is a pyrrolo-pyrazole and small molecule Aurora kinases inhibitor with IC50 of 13, 79, and 61 nM
2015-12-25 16:48 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1252.00/5mg
05mg起訂
詢價(jià)

GSK2801
GSK2801 is a potent, selective and cell active acetyl-lysine competitive inhibitor of BAZ2A(Kd=136 nM) and BAZ2B(Kd=257
2015-12-25 16:41 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

800.00/5mg
05mg起訂
詢價(jià)

NVP-BEP800
NVP-BEP800(VER82576) is a novel, fully synthetic, oral Hsp90 inhibitor with an IC50 of 0.0580.006 M.IC50 Value: 58 nMTar
2015-12-25 16:38 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1252.00/5mg
05mg起訂
詢價(jià)

TMP269
TMP269 is a novel and selective class IIa histone deacetylase inhibitor with IC50s of 126/80/36/9 nM for HDAC 4/5/7/9, r
2015-12-25 16:36 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

4400.00/10mg
010mg起訂
詢價(jià)

EPZ-5676
EPZ-5676 is a potent and selective aminonucleoside inhibitor of DOT1L histone methyltransferase with Ki of 80 pM; demons
2015-12-24 17:11 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1989.00/10mg
010mg起訂
詢價(jià)

GW1929
GW1929 is a synthetic peroxisome proliferator-activated receptor- (PPAR) agonist with IC50 of 6.2 nM and 13 nM for human
2015-12-24 17:09 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1302.00/10mg
010mg起訂
詢價(jià)

GSK126
GSK126 is a potent, highly selective, S-adenosyl-methionine-competitive, small-molecule inhibitor of EZH2 methyltransfer
2015-12-24 17:07 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

781.00/5mg
05mg起訂
詢價(jià)

CGK733
CGK 733 is a small molecule inhibitor reportedly targeting the kinase activities of ATM and ATR.IC50 Value:Target: ATM/A
2015-12-24 17:05 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1083.00/10mg
010mg起訂
詢價(jià)

MG 149
MG149 is a selective and potent Tip60 inhibitor with IC50 of 74 uM, similar potentcy for MOF(IC50= 47 uM); little potent
2015-12-24 17:03 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1209.00/5mg
05mg起訂
詢價(jià)

CGK733
CGK 733 is a small molecule inhibitor reportedly targeting the kinase activities of ATM and ATR.IC50 Value:Target: ATM/A
2015-12-24 17:01 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1083.00/10mg
010mg起訂
詢價(jià)

ELR510444
ELR510444 is a novel microtubule disruptor; inhibits MDA-MB-231 cell proliferation with IC50 of 30.9 nM; not a substrate
2015-12-24 16:59 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1400.00/5mg
05mg起訂
詢價(jià)

3-Deazaneplanocin A
3-Deazaneplanocin A (DZNep) is an attractive epigenetic anticancer agent through the inhibition of the cellular enhancer
2015-12-24 16:58 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]